Global Oral Contrast Agent Market Research Report 2021-2027

  • receipt Report ID : 215610
  • calendar_today Published On: May, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare

The Oral Contrast Agent market report offers in-dept analysis on the global market size, market share, market growth, sales analysis, regional analysis, market developments, opportunities, and forecasts that will help you in strategizing and expanding your business.

As per the most recent analysis conducted by our research team, the global Oral Contrast Agent market size is projected to reach US$ XX million by 2027 from US $ XX million in 2020 at a CAGR of XX% during 2021-2027.

The report included detailed analysis on the Oral Contrast Agent production capacity, its market share by manufacturers, growth rate, regional production capacity, ex-factory rate, and other important data points. The report also covers Oral Contrast Agent consumption globally as well as thorough bifurcation into regional and country wise consumption.

The research team goes an additional mile to comprehensively cover other important aspects on Oral Contrast Agent market such as the market dynamics, market segmentation, competition, growth prospects, and growth strategies. The buyers of this report will have access to exclusive data that covers market share by applications, manufacturers, regions, and countries. The document also covers market size by type, market competition by manufacturers, sales volume, growth rate, revenue, price and gross margins. Moreover, the authors of this report provide authentic calculations and estimations for global revenue and volume by type segments for Oral Contrast Agent market covering the period 2016-2027.

This report includes the following key manufacturers. We can also add other companies of your choice and customize the report as per your requirements.

  • GE Healthcare (US)
  • Bracco Imaging (Italy)
  • Bayer HealthCare (Germany)
  • Guerbet (France)
  • Lantheus (US)
  • Daiichi Sankyo (Japan)
  • Unijules Life Sciences (India)
  • J.B. Chemicals and Pharmaceuticals (India)
  • Spago Nanomedicine (Sweden)
  • Taejoon Pharm (South Korea)
  • Jodas (India)
  • Magnus Health (India)

Market Segment by Type

  • Barium-based Contrast Media
  • Iodinated Contrast Media
  • Gadolinium-based Contrast Media
  • Microbubble Contrast Media

Market Segment by Application

  • Cardiovascular Disorders
  • Cancer
  • Gastrointestinal Disorders
  • Musculoskeletal Disorders
  • Neurological Disorders
  • Nephrological Disorders

Market Segment by Regions and Countries

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, India, Japan, Taiwan, South Korea, Australia, Indonesia, Singapore, Malaysia, Rest of Asia-Pacific)
  • Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
  • Central & South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Turkey, Rest of Middle East & Africa)

The study objectives of this report are:

  • Overview of the Oral Contrast Agent market
  • Analysis on key market segments
  • Key manufacturer analysis based on production, sales, and revenue
  • Oral Contrast Agent market regional and country wise analysis for production and consumption
  • Study the forecast of market in respect to manufacturers, segments, and regions
  • Identify significant trends and factors driving the market growth
  • Analyse the available opportunities in the market by tracing high growth segments
  • Analyse competitive developments like acquisitions, expansions, product launches, agreements, etc.
  • Study the growth strategies of key manufacturers
  • SWOT analysis

In this study, the years considered to estimate the market size of Oral Contrast Agent are as follows:

History Year: 2016-2020

Base Year: 2020

Estimated Year: 2021

Forecast Year 2021 to 2027

Available Customizations

Market Research Place offers customizations according to the client's specific needs. The report can be customized on the basis of manufacturers, regions, applications, etc. Contact us to know more about the customization options.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Oral Contrast Agent Market Size Growth Rate by Type

1.2.2 Barium-based Contrast Media

1.2.3 Iodinated Contrast Media

1.2.4 Gadolinium-based Contrast Media

1.2.5 Microbubble Contrast Media

1.3 Market Segment by Application

1.3.1 Global Oral Contrast Agent Market Share by Application (2016 VS 2021 VS 2027)

1.3.2 Cardiovascular Disorders

1.3.3 Cancer

1.3.4 Gastrointestinal Disorders

1.3.5 Musculoskeletal Disorders

1.3.6 Neurological Disorders

1.3.7 Nephrological Disorders

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Oral Contrast Agent Market Size (2016-2027)

2.1.1 Global Oral Contrast Agent Revenue (2016-2027)

2.1.2 Global Oral Contrast Agent Sales (2016-2027)

2.2 Global Oral Contrast Agent Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027

2.2.1 Global Oral Contrast Agent Sales by Regions (2016-2021)

2.2.2 Global Oral Contrast Agent Revenue by Regions (2016-2021)

2.3 Global Oral Contrast Agent Market Size Forecast by Region

2.3.1 Global Oral Contrast Agent Sales Forecast by Region (2022-2027)

2.3.2 Global Oral Contrast Agent Revenue Forecast by Region (2022-2027)

2.4 Global Top Oral Contrast Agent Regions (Countries) Ranking by Market Size

2.5 Oral Contrast Agent Industry Trends

2.5.1 Oral Contrast Agent Market Trends

2.5.2 Oral Contrast Agent Market Drivers

2.5.3 Oral Contrast Agent Market Challenges

2.5.4 Oral Contrast Agent Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top Oral Contrast Agent Manufacturers by Sales (2016-2021)

3.1.1 Global Oral Contrast Agent Sales by Manufacturers (2016-2021)

3.1.2 Global Oral Contrast Agent Sales Market Share by Manufacturers (2016-2021)

3.1.3 Global 5 and 10 Largest Manufacturers by Oral Contrast Agent Sales in 2020

3.2 Global Top Manufacturers Oral Contrast Agent by Revenue

3.2.1 Global Oral Contrast Agent Revenue by Manufacturers (2016-2021)

3.2.2 Top Oral Contrast Agent Manufacturers Covered: Ranking by Revenue

3.2.3 Global Oral Contrast Agent Revenue Share by Manufacturers (2016-2021)

3.2.4 Global Oral Contrast Agent Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Contrast Agent as of 2020)

3.4 Global Oral Contrast Agent Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Oral Contrast Agent Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Oral Contrast Agent Market

3.7 Key Manufacturers Oral Contrast Agent Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Oral Contrast Agent Market Size by Type

4.1 Global Oral Contrast Agent Historic Market Review by Type (2016-2021)

4.1.1 Global Oral Contrast Agent Sales Market Share by Type (2016-2021)

4.1.2 Global Oral Contrast Agent Revenue Market Share by Type (2016-2021)

4.1.3 Oral Contrast Agent Price by Type (2016-2021)

4.2 Global Oral Contrast Agent Market Estimates and Forecasts by Type (2022-2027)

4.2.1 Global Oral Contrast Agent Sales Forecast by Type (2022-2027)

4.2.2 Global Oral Contrast Agent Revenue Forecast by Type (2022-2027)

4.2.3 Oral Contrast Agent Price Forecast by Type (2022-2027)

5 Global Oral Contrast Agent Market Size by Application

5.1 Global Oral Contrast Agent Historic Market Review by Application (2016-2021)

5.1.1 Global Oral Contrast Agent Sales Market Share by Application (2016-2021)

5.1.2 Global Oral Contrast Agent Revenue Market Share by Application (2016-2021)

5.1.3 Oral Contrast Agent Price by Application (2016-2021)

5.2 Global Oral Contrast Agent Market Estimates and Forecasts by Application (2022-2027)

5.2.1 Global Oral Contrast Agent Sales Forecast by Application (2022-2027)

5.2.2 Global Oral Contrast Agent Revenue Forecast by Application (2022-2027)

5.2.3 Oral Contrast Agent Price Forecast by Application (2022-2027)

6 North America

6.1 North America Oral Contrast Agent Sales Breakdown by Company

6.1.1 North America Oral Contrast Agent Sales by Company (2016-2027)

6.1.2 North America Oral Contrast Agent Revenue by Company (2016-2027)

6.2 North America Oral Contrast Agent Market Size by Type (2016-2027)

6.2.1 North America Oral Contrast Agent Sales by Type (2016-2027)

6.2.2 North America Oral Contrast Agent Revenue by Type (2016-2027)

6.3 North America Oral Contrast Agent Market Size by Application (2016-2027)

6.3.1 North America Oral Contrast Agent Sales by Application (2016-2027)

6.3.2 North America Oral Contrast Agent Revenue by Application (2016-2027)

6.4 North America Oral Contrast Agent Market Size by Country

6.4.1 North America Oral Contrast Agent Sales by Country (2016-2027)

6.4.2 North America Oral Contrast Agent Revenue by Country (2016-2027)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Oral Contrast Agent Sales Breakdown by Company

7.1.1 Europe Oral Contrast Agent Sales by Company (2016-2027)

7.1.2 Europe Oral Contrast Agent Revenue by Company (2016-2027)

7.2 Europe Oral Contrast Agent Market Size by Type (2016-2027)

7.2.1 Europe Oral Contrast Agent Sales by Type (2016-2027)

7.2.2 Europe Oral Contrast Agent Revenue by Type (2016-2027)

7.3 Europe Oral Contrast Agent Market Size by Application (2016-2027)

7.3.1 Europe Oral Contrast Agent Sales by Application (2016-2027)

7.3.2 Europe Oral Contrast Agent Revenue by Application (2016-2027)

7.4 Europe Oral Contrast Agent Market Size by Country

7.4.1 Europe Oral Contrast Agent Sales by Country (2016-2027)

7.4.2 Europe Oral Contrast Agent Revenue by Country (2016-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific Oral Contrast Agent Sales Breakdown by Company

8.1.1 Asia Pacific Oral Contrast Agent Sales by Company (2016-2027)

8.1.2 Asia Pacific Oral Contrast Agent Revenue by Company (2016-2027)

8.2 Asia Pacific Oral Contrast Agent Market Size by Type (2016-2027)

8.2.1 Asia Pacific Oral Contrast Agent Sales by Type (2016-2027)

8.2.2 Asia Pacific Oral Contrast Agent Revenue by Type (2016-2027)

8.3 Asia Pacific Oral Contrast Agent Market Size by Application (2016-2027)

8.3.1 Asia Pacific Oral Contrast Agent Sales by Application (2016-2027)

8.3.2 Asia Pacific Oral Contrast Agent Revenue by Application (2016-2027)

8.4 Asia Pacific Oral Contrast Agent Market Size by Regions

8.4.1 Asia Pacific Oral Contrast Agent Sales by Regions

8.4.2 Asia Pacific Oral Contrast Agent Revenue by Regions

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

8.4.12 Philippines

8.4.13 Vietnam

9 Latin America

9.1 Latin America Oral Contrast Agent Sales Breakdown by Company

9.1.1 Latin America Oral Contrast Agent Sales by Company (2016-2027)

9.1.2 Latin America Oral Contrast Agent Revenue by Company (2016-2027)

9.2 Latin America Oral Contrast Agent Market Size by Type (2016-2027)

9.2.1 Latin America Oral Contrast Agent Sales by Type (2016-2027)

9.2.2 Latin America Oral Contrast Agent Revenue by Type (2016-2027)

9.3 Latin America Oral Contrast Agent Market Size by Application (2016-2027)

9.3.1 Latin America Oral Contrast Agent Sales by Application (2016-2027)

9.3.2 Latin America Oral Contrast Agent Revenue by Application (2016-2027)

9.4 Latin America Oral Contrast Agent Market Size by Country

9.4.1 Latin America Oral Contrast Agent Sales by Country (2016-2027)

9.4.2 Latin America Oral Contrast Agent Revenue by Country (2016-2027)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Oral Contrast Agent Sales Breakdown by Company

10.1.1 Middle East and Africa Oral Contrast Agent Sales by Company (2016-2027)

10.1.2 Middle East and Africa Oral Contrast Agent Revenue by Company (2016-2027)

10.2 Middle East and Africa Oral Contrast Agent Market Size by Type (2016-2027)

10.2.1 Middle East and Africa Oral Contrast Agent Sales by Type (2016-2027)

10.2.2 Middle East and Africa Oral Contrast Agent Revenue by Type (2016-2027)

10.3 Middle East and Africa Oral Contrast Agent Market Size by Application (2016-2027)

10.3.1 Middle East and Africa Oral Contrast Agent Sales by Application (2016-2027)

10.3.2 Middle East and Africa Oral Contrast Agent Revenue by Application (2016-2027)

10.4 Middle East and Africa Oral Contrast Agent Market Size by Country

10.4.1 Middle East and Africa Oral Contrast Agent Sales by Country (2016-2027)

10.4.2 Middle East and Africa Oral Contrast Agent Revenue by Country (2016-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Company Profiles

11.1 GE Healthcare (US)

11.1.1 GE Healthcare (US) Corporation Information

11.1.2 GE Healthcare (US) Overview

11.1.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.1.4 GE Healthcare (US) Oral Contrast Agent Products and Services

11.1.5 GE Healthcare (US) Oral Contrast Agent SWOT Analysis

11.1.6 GE Healthcare (US) Recent Developments

11.2 Bracco Imaging (Italy)

11.2.1 Bracco Imaging (Italy) Corporation Information

11.2.2 Bracco Imaging (Italy) Overview

11.2.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.2.4 Bracco Imaging (Italy) Oral Contrast Agent Products and Services

11.2.5 Bracco Imaging (Italy) Oral Contrast Agent SWOT Analysis

11.2.6 Bracco Imaging (Italy) Recent Developments

11.3 Bayer HealthCare (Germany)

11.3.1 Bayer HealthCare (Germany) Corporation Information

11.3.2 Bayer HealthCare (Germany) Overview

11.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.3.4 Bayer HealthCare (Germany) Oral Contrast Agent Products and Services

11.3.5 Bayer HealthCare (Germany) Oral Contrast Agent SWOT Analysis

11.3.6 Bayer HealthCare (Germany) Recent Developments

11.4 Guerbet (France)

11.4.1 Guerbet (France) Corporation Information

11.4.2 Guerbet (France) Overview

11.4.3 Guerbet (France) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.4.4 Guerbet (France) Oral Contrast Agent Products and Services

11.4.5 Guerbet (France) Oral Contrast Agent SWOT Analysis

11.4.6 Guerbet (France) Recent Developments

11.5 Lantheus (US)

11.5.1 Lantheus (US) Corporation Information

11.5.2 Lantheus (US) Overview

11.5.3 Lantheus (US) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.5.4 Lantheus (US) Oral Contrast Agent Products and Services

11.5.5 Lantheus (US) Oral Contrast Agent SWOT Analysis

11.5.6 Lantheus (US) Recent Developments

11.6 Daiichi Sankyo (Japan)

11.6.1 Daiichi Sankyo (Japan) Corporation Information

11.6.2 Daiichi Sankyo (Japan) Overview

11.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Products and Services

11.6.5 Daiichi Sankyo (Japan) Oral Contrast Agent SWOT Analysis

11.6.6 Daiichi Sankyo (Japan) Recent Developments

11.7 Unijules Life Sciences (India)

11.7.1 Unijules Life Sciences (India) Corporation Information

11.7.2 Unijules Life Sciences (India) Overview

11.7.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.7.4 Unijules Life Sciences (India) Oral Contrast Agent Products and Services

11.7.5 Unijules Life Sciences (India) Oral Contrast Agent SWOT Analysis

11.7.6 Unijules Life Sciences (India) Recent Developments

11.8 J.B. Chemicals and Pharmaceuticals (India)

11.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporation Information

11.8.2 J.B. Chemicals and Pharmaceuticals (India) Overview

11.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.8.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Products and Services

11.8.5 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent SWOT Analysis

11.8.6 J.B. Chemicals and Pharmaceuticals (India) Recent Developments

11.9 Spago Nanomedicine (Sweden)

11.9.1 Spago Nanomedicine (Sweden) Corporation Information

11.9.2 Spago Nanomedicine (Sweden) Overview

11.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.9.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Products and Services

11.9.5 Spago Nanomedicine (Sweden) Oral Contrast Agent SWOT Analysis

11.9.6 Spago Nanomedicine (Sweden) Recent Developments

11.10 Taejoon Pharm (South Korea)

11.10.1 Taejoon Pharm (South Korea) Corporation Information

11.10.2 Taejoon Pharm (South Korea) Overview

11.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.10.4 Taejoon Pharm (South Korea) Oral Contrast Agent Products and Services

11.10.5 Taejoon Pharm (South Korea) Oral Contrast Agent SWOT Analysis

11.10.6 Taejoon Pharm (South Korea) Recent Developments

11.11 Jodas (India)

11.11.1 Jodas (India) Corporation Information

11.11.2 Jodas (India) Overview

11.11.3 Jodas (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.11.4 Jodas (India) Oral Contrast Agent Products and Services

11.11.5 Jodas (India) Recent Developments

11.12 Magnus Health (India)

11.12.1 Magnus Health (India) Corporation Information

11.12.2 Magnus Health (India) Overview

11.12.3 Magnus Health (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.12.4 Magnus Health (India) Oral Contrast Agent Products and Services

11.12.5 Magnus Health (India) Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 Oral Contrast Agent Value Chain Analysis

12.2 Oral Contrast Agent Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Oral Contrast Agent Production Mode & Process

12.4 Oral Contrast Agent Sales and Marketing

12.4.1 Oral Contrast Agent Sales Channels

12.4.2 Oral Contrast Agent Distributors

12.5 Oral Contrast Agent Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

List of Tables

Table 1. Global Oral Contrast Agent Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)

Table 2. Major Manufacturers of Barium-based Contrast Media

Table 3. Major Manufacturers of Iodinated Contrast Media

Table 4. Major Manufacturers of Gadolinium-based Contrast Media

Table 5. Major Manufacturers of Microbubble Contrast Media

Table 6. Global Oral Contrast Agent Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)

Table 7. Global Market Oral Contrast Agent Market Size (US$ Million) by Region: 2016 VS 2021 VS 2027

Table 8. Global Oral Contrast Agent Sales by Region (2016-2021) & (K Pcs)

Table 9. Global Oral Contrast Agent Sales Market Share by Region (2016-2021)

Table 10. Global Oral Contrast Agent Revenue by Region (2016-2021) & (US$ Million)

Table 11. Global Oral Contrast Agent Revenue Market Share by Region (2016-2021)

Table 12. Global Oral Contrast Agent Sales Forecast by Region (2022-2027) & (K Pcs)

Table 13. Global Oral Contrast Agent Sales Market Share Forecast by Region (2022-2027)

Table 14. Global Oral Contrast Agent Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 15. Global Oral Contrast Agent Revenue Market Share Forecast by Region (2022-2027)

Table 16. Top Oral Contrast Agent Regions (Countries) Ranking by Market Size (US$ Million) in 2020

Table 17. Oral Contrast Agent Market Trends

Table 18. Oral Contrast Agent Market Drivers

Table 19. Oral Contrast Agent Market Challenges

Table 20. Oral Contrast Agent Market Restraints

Table 21. Global Oral Contrast Agent Sales by Manufacturers (2016-2021) & (K Pcs)

Table 22. Global Oral Contrast Agent Sales Share by Manufacturers (2016-2021)

Table 23. Global Oral Contrast Agent Revenue by Manufacturers (2016-2021) & (US$ Million)

Table 24. Ranking of Global Top Oral Contrast Agent Manufacturers by Revenue (US$ Million) in 2020

Table 25. Oral Contrast Agent Revenue Share by Manufacturers (2016-2021)

Table 26. Global Oral Contrast Agent Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Contrast Agent as of 2020)

Table 28. Key Manufacturers Oral Contrast Agent Average Selling Price (ASP) & (2016-2021) & (USD/Pcs)

Table 29. Key Manufacturers Oral Contrast Agent Plants/Factories Distribution

Table 30. Key Manufacturers Oral Contrast Agent Area Served

Table 31. Date of Key Manufacturers Enter into Oral Contrast Agent Market

Table 32. Key Manufacturers Oral Contrast Agent Product Type

Table 33. Mergers & Acquisitions, Expansion Plans

Table 34. Global Oral Contrast Agent Sales (K Pcs) by Type (2016-2021)

Table 35. Global Oral Contrast Agent Sales Share by Type (2016-2021)

Table 36. Global Oral Contrast Agent Revenue (US$ Million) Market Share by Type (2016-2021)

Table 37. Global Oral Contrast Agent Price (K Pcs) by Type (2016-2021)

Table 38. Global Oral Contrast Agent Sales (K Pcs) by Type (2022-2027)

Table 39. Global Oral Contrast Agent Sales Share by Type (2022-2027)

Table 40. Global Oral Contrast Agent Revenue (US$ Million) Market Share by Type (2022-2027)

Table 41. Global Oral Contrast Agent Revenue Share by Type (2022-2027)

Table 42. Global Oral Contrast Agent Price (K Pcs) by Type (2022-2027)

Table 43. Global Oral Contrast Agent Sales (K Pcs) by Application (2016-2021)

Table 44. Global Oral Contrast Agent Sales Share by Application (2016-2021)

Table 45. Global Oral Contrast Agent Revenue (US$ Million) Market Share by Application (2016-2021)

Table 46. Global Oral Contrast Agent Price (K Pcs) by Application (2016-2021)

Table 47. Global Oral Contrast Agent Sales (K Pcs) by Application (2022-2027)

Table 48. Global Oral Contrast Agent Sales Share by Application (2022-2027)

Table 49. Global Oral Contrast Agent Revenue (US$ Million) Market Share by Application (2022-2027)

Table 50. Global Oral Contrast Agent Revenue Share by Application (2022-2027)

Table 51. Global Oral Contrast Agent Price (K Pcs) by Application (2022-2027)

Table 52. North America Oral Contrast Agent Sales by Company (2016-2021) & (K Pcs)

Table 53. North America Oral Contrast Agent Sales Market Share by Company (2016-2021)

Table 54. North America Oral Contrast Agent Revenue by Company (2016-2021) & (US$ Million)

Table 55. North America Oral Contrast Agent Revenue Market Share by Company (2016-2021)

Table 56. North America Oral Contrast Agent Sales by Application (2016-2021) & (K Pcs)

Table 57. North America Oral Contrast Agent Sales by Application (2022-2027) & (K Pcs)

Table 58. North America Oral Contrast Agent Revenue by Application (2016-2021) & (US$ Million)

Table 59. North America Oral Contrast Agent Revenue by Application (2022-2027) & (US$ Million)

Table 60. North America Oral Contrast Agent Sales by Application (2016-2021) & (K Pcs)

Table 61. North America Oral Contrast Agent Sales by Application (2022-2027) & (K Pcs)

Table 62. North America Oral Contrast Agent Revenue by Application (2016-2021) & (US$ Million)

Table 63. North America Oral Contrast Agent Revenue by Application (2022-2027) & (US$ Million)

Table 64. North America Oral Contrast Agent Sales by Country (2016-2021) & (K Pcs)

Table 65. North America Oral Contrast Agent Sales by Country (2022-2027) & (K Pcs)

Table 66. North America Oral Contrast Agent Revenue by Country (2016-2021) & (US$ Million)

Table 67. North America Oral Contrast Agent Revenue by Country (2022-2027) & (US$ Million)

Table 68. Europe Oral Contrast Agent Sales by Company (2016-2021) & (K Pcs)

Table 69. Europe Oral Contrast Agent Sales Market Share by Company (2016-2021)

Table 70. Europe Oral Contrast Agent Revenue by Company (2016-2021) & (US$ Million)

Table 71. Europe Oral Contrast Agent Revenue Market Share by Company (2016-2021)

Table 72. Europe Oral Contrast Agent Sales by Application (2016-2021) & (K Pcs)

Table 73. Europe Oral Contrast Agent Sales by Application (2022-2027) & (K Pcs)

Table 74. Europe Oral Contrast Agent Revenue by Application (2016-2021) & (US$ Million)

Table 75. Europe Oral Contrast Agent Revenue by Application (2022-2027) & (US$ Million)

Table 76. Europe Oral Contrast Agent Sales by Application (2016-2021) & (K Pcs)

Table 77. Europe Oral Contrast Agent Sales by Application (2022-2027) & (K Pcs)

Table 78. Europe Oral Contrast Agent Revenue by Application (2016-2021) & (US$ Million)

Table 79. Europe Oral Contrast Agent Revenue by Application (2022-2027) & (US$ Million)

Table 80. Europe Oral Contrast Agent Sales by Country (2016-2021) & (K Pcs)

Table 81. Europe Oral Contrast Agent Sales by Country (2022-2027) & (K Pcs)

Table 82. Europe Oral Contrast Agent Revenue by Country (2016-2021) & (US$ Million)

Table 83. Europe Oral Contrast Agent Revenue by Country (2022-2027) & (US$ Million)

Table 84. Asia Pacific Oral Contrast Agent Sales by Company (2016-2021) & (K Pcs)

Table 85. Asia Pacific Oral Contrast Agent Sales Market Share by Company (2016-2021)

Table 86. Asia Pacific Oral Contrast Agent Revenue by Company (2016-2021) & (US$ Million)

Table 87. Asia Pacific Oral Contrast Agent Revenue Market Share by Company (2016-2021)

Table 88. Asia Pacific Oral Contrast Agent Sales by Application (2016-2021) & (K Pcs)

Table 89. Asia Pacific Oral Contrast Agent Sales by Application (2022-2027) & (K Pcs)

Table 90. Asia Pacific Oral Contrast Agent Revenue by Application (2016-2021) & (US$ Million)

Table 91. Asia Pacific Oral Contrast Agent Revenue by Application (2022-2027) & (US$ Million)

Table 92. Asia Pacific Oral Contrast Agent Sales by Application (2016-2021) & (K Pcs)

Table 93. Asia Pacific Oral Contrast Agent Sales by Application (2022-2027) & (K Pcs)

Table 94. Asia Pacific Oral Contrast Agent Revenue by Application (2016-2021) & (US$ Million)

Table 95. Asia Pacific Oral Contrast Agent Revenue by Application (2022-2027) & (US$ Million)

Table 96. Asia Pacific Oral Contrast Agent Sales by Region (2016-2021) & (K Pcs)

Table 97. Asia Pacific Oral Contrast Agent Sales by Region (2022-2027) & (K Pcs)

Table 98. Asia Pacific Oral Contrast Agent Revenue by Region (2016-2021) & (US$ Million)

Table 99. Asia Pacific Oral Contrast Agent Revenue by Region (2022-2027) & (US$ Million)

Table 100. Latin America Oral Contrast Agent Sales by Company (2016-2021) & (K Pcs)

Table 101. Latin America Oral Contrast Agent Sales Market Share by Company (2016-2021)

Table 102. Latin America Oral Contrast Agent Revenue by Company (2016-2021) & (US$ Million)

Table 103. Latin America Oral Contrast Agent Revenue Market Share by Company (2016-2021)

Table 104. Latin America Oral Contrast Agent Sales by Application (2016-2021) & (K Pcs)

Table 105. Latin America Oral Contrast Agent Sales by Application (2022-2027) & (K Pcs)

Table 106. Latin America Oral Contrast Agent Revenue by Application (2016-2021) & (US$ Million)

Table 107. Latin America Oral Contrast Agent Revenue by Application (2022-2027) & (US$ Million)

Table 108. Latin America Oral Contrast Agent Sales by Application (2016-2021) & (K Pcs)

Table 109. Latin America Oral Contrast Agent Sales by Application (2022-2027) & (K Pcs)

Table 110. Latin America Oral Contrast Agent Revenue by Application (2016-2021) & (US$ Million)

Table 111. Latin America Oral Contrast Agent Revenue by Application (2022-2027) & (US$ Million)

Table 112. Latin America Oral Contrast Agent Sales by Country (2016-2021) & (K Pcs)

Table 113. Latin America Oral Contrast Agent Sales by Country (2022-2027) & (K Pcs)

Table 114. Latin America Oral Contrast Agent Revenue by Country (2016-2021) & (US$ Million)

Table 115. Latin America Oral Contrast Agent Revenue by Country (2022-2027) & (US$ Million)

Table 116. Middle East and Africa Oral Contrast Agent Sales by Company (2016-2021) & (K Pcs)

Table 117. Middle East and Africa Oral Contrast Agent Sales Market Share by Company (2016-2021)

Table 118. Middle East and Africa Oral Contrast Agent Revenue by Company (2016-2021) & (US$ Million)

Table 119. Middle East and Africa Oral Contrast Agent Revenue Market Share by Company (2016-2021)

Table 120. Middle East and Africa Oral Contrast Agent Sales by Application (2016-2021) & (K Pcs)

Table 121. Middle East and Africa Oral Contrast Agent Sales by Application (2022-2027) & (K Pcs)

Table 122. Middle East and Africa Oral Contrast Agent Revenue by Application (2016-2021) & (US$ Million)

Table 123. Middle East and Africa Oral Contrast Agent Revenue by Application (2022-2027) & (US$ Million)

Table 124. Middle East and Africa Oral Contrast Agent Sales by Application (2016-2021) & (K Pcs)

Table 125. Middle East and Africa Oral Contrast Agent Sales by Application (2022-2027) & (K Pcs)

Table 126. Middle East and Africa Oral Contrast Agent Revenue by Application (2016-2021) & (US$ Million)

Table 127. Middle East and Africa Oral Contrast Agent Revenue by Application (2022-2027) & (US$ Million)

Table 128. Middle East and Africa Oral Contrast Agent Sales by Country (2016-2021) & (K Pcs)

Table 129. Middle East and Africa Oral Contrast Agent Sales by Country (2022-2027) & (K Pcs)

Table 130. Middle East and Africa Oral Contrast Agent Revenue by Country (2016-2021) & (US$ Million)

Table 131. Middle East and Africa Oral Contrast Agent Revenue by Country (2022-2027) & (US$ Million)

Table 132. GE Healthcare (US) Corporation Information

Table 133. GE Healthcare (US) Description and Overview

Table 134. GE Healthcare (US) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 135. GE Healthcare (US) Oral Contrast Agent Product and Services

Table 136. GE Healthcare (US) Oral Contrast Agent SWOT Analysis

Table 137. GE Healthcare (US) Recent Developments

Table 138. Bracco Imaging (Italy) Corporation Information

Table 139. Bracco Imaging (Italy) Description and Overview

Table 140. Bracco Imaging (Italy) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 141. Bracco Imaging (Italy) Oral Contrast Agent Product and Services

Table 142. Bracco Imaging (Italy) Oral Contrast Agent SWOT Analysis

Table 143. Bracco Imaging (Italy) Recent Developments

Table 144. Bayer HealthCare (Germany) Corporation Information

Table 145. Bayer HealthCare (Germany) Description and Overview

Table 146. Bayer HealthCare (Germany) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 147. Bayer HealthCare (Germany) Oral Contrast Agent Product and Services

Table 148. Bayer HealthCare (Germany) Oral Contrast Agent SWOT Analysis

Table 149. Bayer HealthCare (Germany) Recent Developments

Table 150. Guerbet (France) Corporation Information

Table 151. Guerbet (France) Description and Overview

Table 152. Guerbet (France) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 153. Guerbet (France) Oral Contrast Agent Product and Services

Table 154. Guerbet (France) Oral Contrast Agent SWOT Analysis

Table 155. Guerbet (France) Recent Developments

Table 156. Lantheus (US) Corporation Information

Table 157. Lantheus (US) Description and Overview

Table 158. Lantheus (US) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 159. Lantheus (US) Oral Contrast Agent Product and Services

Table 160. Lantheus (US) Oral Contrast Agent SWOT Analysis

Table 161. Lantheus (US) Recent Developments

Table 162. Daiichi Sankyo (Japan) Corporation Information

Table 163. Daiichi Sankyo (Japan) Description and Overview

Table 164. Daiichi Sankyo (Japan) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 165. Daiichi Sankyo (Japan) Oral Contrast Agent Product and Services

Table 166. Daiichi Sankyo (Japan) Oral Contrast Agent SWOT Analysis

Table 167. Daiichi Sankyo (Japan) Recent Developments

Table 168. Unijules Life Sciences (India) Corporation Information

Table 169. Unijules Life Sciences (India) Description and Overview

Table 170. Unijules Life Sciences (India) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 171. Unijules Life Sciences (India) Oral Contrast Agent Product and Services

Table 172. Unijules Life Sciences (India) Oral Contrast Agent SWOT Analysis

Table 173. Unijules Life Sciences (India) Recent Developments

Table 174. J.B. Chemicals and Pharmaceuticals (India) Corporation Information

Table 175. J.B. Chemicals and Pharmaceuticals (India) Description and Overview

Table 176. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 177. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product and Services

Table 178. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent SWOT Analysis

Table 179. J.B. Chemicals and Pharmaceuticals (India) Recent Developments

Table 180. Spago Nanomedicine (Sweden) Corporation Information

Table 181. Spago Nanomedicine (Sweden) Description and Overview

Table 182. Spago Nanomedicine (Sweden) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 183. Spago Nanomedicine (Sweden) Oral Contrast Agent Product and Services

Table 184. Spago Nanomedicine (Sweden) Oral Contrast Agent SWOT Analysis

Table 185. Spago Nanomedicine (Sweden) Recent Developments

Table 186. Taejoon Pharm (South Korea) Corporation Information

Table 187. Taejoon Pharm (South Korea) Description and Overview

Table 188. Taejoon Pharm (South Korea) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 189. Taejoon Pharm (South Korea) Oral Contrast Agent Product and Services

Table 190. Taejoon Pharm (South Korea) Oral Contrast Agent SWOT Analysis

Table 191. Taejoon Pharm (South Korea) Recent Developments

Table 192. Jodas (India) Corporation Information

Table 193. Jodas (India) Description and Overview

Table 194. Jodas (India) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 195. Jodas (India) Oral Contrast Agent Product and Services

Table 196. Jodas (India) Recent Developments

Table 197. Magnus Health (India) Corporation Information

Table 198. Magnus Health (India) Description and Overview

Table 199. Magnus Health (India) Oral Contrast Agent Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 200. Magnus Health (India) Oral Contrast Agent Product and Services

Table 201. Magnus Health (India) Recent Developments

Table 202. Key Raw Materials Lists

Table 203. Raw Materials Key Suppliers Lists

Table 204. Oral Contrast Agent Distributors List

Table 205. Oral Contrast Agent Customers List

Table 206. Research Programs/Design for This Report

Table 207. Key Data Information from Secondary Sources

Table 208. Key Data Information from Primary Sources

List of Figures

Figure 1. Oral Contrast Agent Product Picture

Figure 2. Global Oral Contrast Agent Sales Market Share by Type in 2020 & 2027

Figure 3. Barium-based Contrast Media Picture

Figure 4. Iodinated Contrast Media Picture

Figure 5. Gadolinium-based Contrast Media Picture

Figure 6. Microbubble Contrast Media Picture

Figure 7. Global Oral Contrast Agent Sales Market Share by Application in 2020 & 2027

Figure 8. Cardiovascular Disorders Use Case

Figure 9. Cancer Use Case

Figure 10. Gastrointestinal Disorders Use Case

Figure 11. Musculoskeletal Disorders Use Case

Figure 12. Neurological Disorders Use Case

Figure 13. Nephrological Disorders Use Case

Figure 14. Oral Contrast Agent Report Years Considered

Figure 15. Global Oral Contrast Agent Revenue, (US$ Million), 2016 VS 2021 VS 2027

Figure 16. Global Oral Contrast Agent Market Size 2016-2027 (US$ Million)

Figure 17. Global Oral Contrast Agent Sales (2016-2021) & (K Pcs)

Figure 18. Global Oral Contrast Agent Market Size Market Share by Region: 2020 VS 2027

Figure 19. Global Oral Contrast Agent Sales Market Share by Region (2016-2021)

Figure 20. Global Oral Contrast Agent Sales Market Share by Region in 2020

Figure 21. Global Oral Contrast Agent Revenue Market Share by Region in 2016 VS 2020

Figure 22. Global Oral Contrast Agent Sales Share by Manufacturers In 2020

Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Contrast Agent Sales in 2020

Figure 24. Oral Contrast Agent Revenue Share by Manufacturers In 2020

Figure 25. Oral Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

Figure 26. Global Oral Contrast Agent Revenue Share by Type (2016-2021)

Figure 27. Global Oral Contrast Agent Revenue Growth Rate by Type in 2016 & 2020

Figure 28. Global Oral Contrast Agent Revenue Share by Application (2016-2021)

Figure 29. Global Oral Contrast Agent Revenue Growth Rate by Application in 2016 & 2020

Figure 30. North America Oral Contrast Agent Sales Market Share by Type (2016-2027)

Figure 31. North America Oral Contrast Agent Revenue Market Share by Type (2016-2027)

Figure 32. North America Oral Contrast Agent Sales Market Share by Application (2016-2027)

Figure 33. North America Oral Contrast Agent Revenue Market Share by Application (2016-2027)

Figure 34. North America Oral Contrast Agent Sales Share by Country (2016-2027)

Figure 35. North America Oral Contrast Agent Revenue Share by Country (2016-2027)

Figure 36. U.S. Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 37. Canada Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 38. Europe Oral Contrast Agent Sales Market Share by Type (2016-2027)

Figure 39. Europe Oral Contrast Agent Revenue Market Share by Type (2016-2027)

Figure 40. Europe Oral Contrast Agent Sales Market Share by Application (2016-2027)

Figure 41. Europe Oral Contrast Agent Revenue Market Share by Application (2016-2027)

Figure 42. Europe Oral Contrast Agent Sales Share by Country (2016-2027)

Figure 43. Europe Oral Contrast Agent Revenue Share by Country (2016-2027)

Figure 44. Germany Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 45. France Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 46. U.K. Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 47. Italy Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 48. Russia Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 49. Asia Pacific Oral Contrast Agent Sales Market Share by Type (2016-2027)

Figure 50. Asia Pacific Oral Contrast Agent Revenue Market Share by Type (2016-2027)

Figure 51. Asia Pacific Oral Contrast Agent Sales Market Share by Application (2016-2027)

Figure 52. Asia Pacific Oral Contrast Agent Revenue Market Share by Application (2016-2027)

Figure 53. Asia Pacific Oral Contrast Agent Sales Share by Region (2016-2027)

Figure 54. Asia Pacific Oral Contrast Agent Revenue Share by Region (2016-2027)

Figure 55. China Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 56. Japan Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 57. South Korea Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 58. India Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 59. Australia Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 60. Taiwan Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 61. Indonesia Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 62. Thailand Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 63. Malaysia Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 64. Philippines Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 65. Vietnam Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 66. Latin America Oral Contrast Agent Sales Market Share by Type (2016-2027)

Figure 67. Latin America Oral Contrast Agent Revenue Market Share by Type (2016-2027)

Figure 68. Latin America Oral Contrast Agent Sales Market Share by Application (2016-2027)

Figure 69. Latin America Oral Contrast Agent Revenue Market Share by Application (2016-2027)

Figure 70. Latin America Oral Contrast Agent Sales Share by Country (2016-2027)

Figure 71. Latin America Oral Contrast Agent Revenue Share by Country (2016-2027)

Figure 72. Mexico Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 73. Brazil Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 74. Argentina Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 75. Middle East and Africa Oral Contrast Agent Sales Market Share by Type (2016-2027)

Figure 76. Middle East and Africa Oral Contrast Agent Revenue Market Share by Type (2016-2027)

Figure 77. Middle East and Africa Oral Contrast Agent Sales Market Share by Application (2016-2027)

Figure 78. Middle East and Africa Oral Contrast Agent Revenue Market Share by Application (2016-2027)

Figure 79. Middle East and Africa Oral Contrast Agent Sales Share by Country (2016-2027)

Figure 80. Middle East and Africa Oral Contrast Agent Revenue Share by Country (2016-2027)

Figure 81. Turkey Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 82. Saudi Arabia Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 83. UAE Oral Contrast Agent Revenue (2016-2027) & (US$ Million)

Figure 84. Oral Contrast Agent Value Chain

Figure 85. Oral Contrast Agent Production Process

Figure 86. Channels of Distribution

Figure 87. Distributors Profiles

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

Please fill the form below, to recieve the report sample


+1